Revenio Group Oyj’s Acquisition of Visionix International
Revenio Group Oyj announced on 13 April 2026 that it will conduct a press conference at 2:00 p.m. to discuss its acquisition of Visionix International. The transaction, which the company describes as a strategic move to become a leading turnkey solutions provider in the global eye‑care market, is expected to be completed by the end of the second quarter of 2026, subject to the approval of Revenio’s shareholders.
Transaction Structure and Financial Terms
| Item | Details |
|---|---|
| Target | LT International, the holding company of Visionix International |
| Enterprise Value | €290 million |
| Purchase Price | €250 million |
| Payment Method | €55.7 million in newly issued Revenio shares; remainder financed with cash, existing cash reserves, a new €130 million term loan, an €80 million bridge loan, and a seller‑financed loan arrangement |
| Debt Repayment | Cash portion and existing liabilities to be repaid through the above financing |
| Completion Timeline | Targeted for the end of Q2 2026 |
| Conditions | Approval of a new share issue of 2,485,797 shares for the sellers and a subsequent €80 million subscription rights issue by the board of directors |
The acquisition will bring Visionix’s revenue stream of more than €250 million and an EBITDA of approximately €48 million into Revenio’s portfolio. Visionix’s workforce exceeds 800 employees, and the combined company is positioned to deliver a broader range of complementary products, software, and customer services.
Strategic Rationale
Revenio stated that the merger of its product and software lines with those of Visionix will create a “leading turnkey solutions provider in the global eye‑care market.” Key expected benefits include:
- Expansion of the total addressable market (TAM) by roughly 2.5 fold through access to new customer bases and markets.
- Accelerated entry into the OCT segment, enhancing the company’s capability in advanced ophthalmic diagnostics.
- Targeted EBITDA improvement of more than €20 million by the end of 2029, achieved through synergy realization and scale efficiencies.
The transaction aligns with Revenio’s objective of accelerating growth and value creation by combining highly complementary product, software, and customer portfolios.
Governance and Shareholder Matters
On the same day, Revenio announced the cancellation of its 2026 Annual General Meeting, stating that the meeting would be rescheduled for a later date. The meeting’s postponement is linked to the ongoing transaction and the need for shareholders to vote on the new share issue and the subsequent subscription rights offering required for the acquisition.
The board will seek shareholders’ approval for:
- The issuance of 2,485,797 new shares to Visionix’s owners as part of the purchase consideration.
- The authorization of the €80 million subscription rights issue that follows the acquisition.
Only after these approvals will the transaction be considered complete.
Market Context
- Market Capitalisation (as of 9 April 2026): €510 million
- Share Price (9 April 2026): €19.64
- 52‑Week Range: €17.36 – €29.80
- Price‑Earnings Ratio: 29.19
The acquisition is expected to modify Revenio’s financial guidance for 2026, with the company cancelling its prior forecast and issuing a revised outlook following the transaction’s completion.
